
- Pharmaceutical Executive-06-01-2008
- Volume 0
- Issue 0
John Orwin, Genentech
S
ONE TO WATCH:
John Orwin, SVP, Sales and Marketing, BioOncology, Genentech
Orwin learned the landscape of onoclogy while working as senior director of oncology marketing at Alza, and then eventually as the franchise VP at J&J's Tibotec division. In 2005, he headed out to Cali to join Genentech, and was promoted the same year to head sales and marketing of its BioOncology division. And it's a good thing: Orwin was part of the commercial genius that built such heavyweights as Avastin, Herceptin, and Rituxan.
Articles in this issue
over 17 years ago
Mary Szela, Abbottover 17 years ago
Mightier Than the Swordover 17 years ago
Keeshia Muhammad, Teva Specialty Pharmaceuticalsover 17 years ago
Eric Floyd, Cephalonover 17 years ago
Nancy Phelan, Wyethover 17 years ago
Tightening the Chainover 17 years ago
Kurt Graves, Vertexover 17 years ago
Wendy Niebler, Shireover 17 years ago
Perfectly ImperfectNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.